Year 2019 / Volume 111 / Number 9
Original
Treatment of a chronic anal fissure with a botulin toxin A injection and fissurectomy

672-676

DOI: 10.17235/reed.2019.6202/2019

Alejandro Andicoechea Agorría, José Manuel del Casar Lizcano, Esther Barbón Remis, Jimy Harol Jara Quezada, José Carlos Fernández Fernández, María del Rosario Sánchez Sánchez, Isabel Quintela Baizán, Francisco Vivoso Piñero,

Abstract
Introduction: pharmacological treatment of a chronic anal fissure (CAF) achieves healing in half of cases and lateral internal sphincterotomy (LIS) is the definite treatment. The objective of this study was to assess the combination of fissurectomy and botulin toxin A (BTA) injection. Methods: this was a retrospective study of 54 patients with anal sphincter hypertonia and CAF treated with an injection of BAT and fissurectomy, after an unsuccessful management with topical nitroglycerin (NGT) for eight weeks. Fissurectomy and an injection of BTA (33 or 50 units) in the internal anal sphincter was performed during the same session. The main outcome measure was the healing rate, with incontinence and the need of LIS as secondary outcomes. Results: two patients were excluded from the study, one due to Crohn’s disease and the other was lost to follow-up. Of the 52 patients included in the study, there were 36 females (70%) and 16 (30%) males, with a mean age of 49 years (range 22-75). Fissure healing was initially achieved in 49 patients (94.2%) and LIS was required in the remaining three patients (5.8%). After initial healing, 18 patients (34.7%) developed 23 recurrences at a mean time of 27 months (5-83 months). Of these patients, healing with conservative sphincter measures was obtained in eleven cases (NGT in eight and repeat fissurectomy and BAT in three); two patients are currently under treatment with NGT and five underwent LIS. Conclusions: BTA injection associated with fissurectomy is a safe and effective procedure in patients with CAF, avoiding the need of LIS in a high percentage of patients.
Share Button
New comment
Comments
No comments for this article
References
1.- Scholefield JH, Bock JU, Marla B y cols. A dose finding study with 0.1%, 0.2%, and 0.4% glyceryl trinitrate ointment in patients with chronic anal fissures. Gut. 2003 Feb; 52(2): 264-9. PubMed PMID: 12524411.
2.- Stewart DB Sr, Gaertner W, Glasgow S y cols. Clinical Practice Guideline for the Management of Anal Fissures. Dis Colon Rectum. 2017 Jan; 60(1): 7-14. PubMed PMID: 27926552.
3.- Simkovic D(1), Smejkal K, Hladík P. Assessment of sphincterotomy results in patients treated for anal fissure. Rev Esp Enferm Dig. 2000 Jun; 92(6): 399-404. PMID: 10985100
4.- Casillas S, Hull TL, Zutshi M y cols. Incontinence after a lateral internal sphincterotomy: are we underestimating it? Dis Colon Rectum. 2005 Jun; 48(6): 1193-9. PubMed PMID: 15906136.
5.- Arroyo A, Montes E, Calderón T y cols. Treatment algorithm for anal fissure. Consensus document of the Spanish Association of Coloproctology and the Coloproctology Division of the Spanish Association of Surgeons. Cir Esp. 2018 May; 96(5): 260-7. PubMed PMID: 29525120.
6.- Lindsey I, Jones OM, Cunningham C y cols. Botulinum toxin as second-line therapy for chronic anal fissure failing 0.2 percent glyceryl trinitrate. Dis Colon Rectum. 2003 Mar; 46(3): 361-6. PubMed PMID: 12626912.
7.- Novell F, Novell-Costa F, Novell J. Topical glyceryl trinitrate in the treatment of anal fissure. Rev Esp Enferm Dig. 2004 Apr; 96(4): 255-8. PubMed PMID: 15117238.
8.- Engel AF, Eijsbouts QA, Balk AG. Fissurectomy and isosorbide dinitrate for chronic fissure in ano not responding to conservative treatment. Br J Surg. 2002 Jan; 89(1): 79-83. PubMed PMID: 11851668.
9.- Lindsey I, Cunningham C, Jones OM y cols. Fissurectomy-botulinum toxin: a novel sphincter-sparing procedure for medically resistant chronic anal fissure. Dis Colon Rectum. 2004 Nov; 47(11): 1947-52. PubMed PMID: 15622590.
10.- Witte ME, Klaase JM, Koop R. Fissurectomy combined with botulinum toxin A injection for medically resistant chronic anal fissures. Colorectal Dis. 2010 Jul; 12(7 Online): e 163-9. PubMed PMID: 19832866.
11.- Lambe GF, Driver CP, Morton S y cols. Fissurectomy as a treatment for anal fissures in children. Ann R Coll Surg Engl. 2000 Jul; 82(4): 254-7. PubMed PMID: 10932659
12.- Scholz T, Hetzer FH, Dindo D y cols. Long-term follow-up after combined fissurectomy and Botox injection for chronic anal fissures. Int J Colorectal Dis. 2007 Sep; 22(9): 1077-81. PubMed PMID: 17262202.
13.- Baraza W, Boereboom C, Shorthouse A y cols. The long-term efficacy of fissurectomy and botulinum toxin injection for chronic anal fissure in females. Dis Colon Rectum. 2008 Feb; 51(2): 239-43. PubMed PMID: 18175186.
14.- Arthur JD, Makin CA, El-Sayed TY y cols. A pilot comparative study of fissurectomy/diltiazem and fissurectomy/botulinum toxin in the treatment of chronic anal fissure. Tech Coloproctol. 2008 Dec; 12(4): 331-6; discussion 336. PubMed PMID: 19018466.
15.- Aivaz O, Rayhanabad J, Nguyen V y cols. Botulinum toxin A with fissurectomy is a viable alternative to lateral internal sphincterotomy for chronic anal fissure. Am Surg. 2009 Oct; 75(10): 925-8. PubMed PMID: 19886136.
16.- Sileri P, Stolfi VM, Franceschilli L y cols. Conservative and surgical treatment of chronic anal fissure: prospective longer term results. J Gastrointest Surg. 2010 May; 14(5): 773-80. PubMed PMID: 20195915.
17.- Barnes TG, Zafrani Z, Abdelrazeq AS. Fissurectomy Combined with High-Dose Botulinum Toxin Is a Safe and Effective Treatment for Chronic Anal Fissure and a Promising Alternative to Surgical Sphincterotomy. Dis Colon Rectum. 2015 Oct; 58(10): 967-73. PubMed PMID: 26347969.
18.- Jorge JM, Wexner SD. Etiology and management of fecal incontinence. Dis Colon
Rectum. 1993 Jan; 36(1): 77-97. Review. PubMed PMID: 8416784.
19.- Minguez M, Herreros B, Espi A y cols. Long-term follow-up (42 months) of chronic anal fissure after healing with botulinum toxin. Gastroenterology. 2002 Jul; 123(1): 112-7. PubMed PMID:12105839.
20.- Siddiqui J, Fowler GE, Zahid A y cols. Treatment of anal fissure: a survey of surgical practice in Australia and New Zealand. Colorectal Dis. 2018 Nov 9. PubMed PMID: 30411476.
21.- Notaras MJ. Lateral subcutaneous sphincterotomy for anal fissure--a new technique. Proc R Soc Med. 1969 Jul 7; 62(7): 713. PubMed PMID: 5803521.
22.- Barbeiro S, Atalaia-Martins C, Marcos P y cols. Long-term outcomes of Botulinum toxin in the treatment of chronic anal fissure: 5 years of follow-up. United European Gastroenterol J. 2017 Mar; 5(2): 293-7. PubMed PMID: 28344798.
23.- Bobkiewicz A, Francuzik W, Krokowicz L y cols. Botulinum Toxin Injection for Treatment of Chronic Anal Fissure: Is There Any Dose-Dependent Efficiency? A Meta-Analysis. World J Surg. 2016 Dec; 40(12): 3064-72. Review. Erratum in: World J Surg. 2016 Dec; 40(12): 3063. PubMed PMID: 27539490.
24: Canelles E, Bernal JC, Berasategui J y cols. Long-term follow-up of chronic anal fissure (CAF) on diltiazem 2% using a telephone questionnaire. Do results change? Rev Esp Enferm Dig. 2015 Apr; 107(4): 216-20. PubMed PMID: 25824920.
25: Kiyak G, Korukluoğlu B, Kuşdemir A y cols. Results of lateral internal sphincterotomy with open technique for chronic anal fissure: evaluation of complications, symptom relief, and incontinence with long-term follow-up. Dig Dis Sci. 2009 Oct; 54(10): 2220-4..PubMed PMID: 19117133
26.- Patti R, Guercio G, Territo V y cols. Advancement flap in the management of chronic anal fissure: a prospective study. Updates Surg. 2012 Jun; 64(2): 101-6. PubMed PMID: 22488270.
Related articles
Citation tools
Andicoechea Agorría A, del Casar Lizcano J, Barbón Remis E, Jara Quezada J, Fernández Fernández J, Sánchez Sánchez M, et all. Treatment of a chronic anal fissure with a botulin toxin A injection and fissurectomy . 6202/2019


Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Metrics
This article has received 1351 visits.
This article has been downloaded 552 times.

Statistics from Dimensions


Statistics from Plum Analytics

Publication history

Received: 30/01/2019

Accepted: 10/03/2019

Online First: 23/07/2019

Published: 05/09/2019

Article revision time: 36 days

Article Online First time: 174 days

Article editing time: 218 days


Share
This article has been rated by 6 readers.
Reader rating:
Valora este artículo:




Asociación Española de Ecografía Digestiva Sociedad Española de Endoscopia Digestiva Sociedad Española de Patología Digestiva
The Spanish Journal of Gastroenterology is the official organ of the Sociedad Española de Patología Digestiva, the Sociedad Española de Endoscopia Digestiva and the Asociación Española de Ecografía Digestiva
Cookie policy Privacy Policy Legal Notice © Copyright 2023 y Creative Commons. The Spanish Journal of Gastroenterology